Edward C Jones-López1, Carlos Acuña-Villaorduña2, Martin Ssebidandi3, Mary Gaeddert2, Rachel W Kubiak2, Irene Ayakaka3, Laura F White4, Moses Joloba5, Alphonse Okwera6, Kevin P Fennelly7. 1. Section of Infectious Diseases, Department of Medicine, Boston Medical Center and Boston University School of Medicine Makerere University-Boston Medical Center Research Collaboration. 2. Section of Infectious Diseases, Department of Medicine, Boston Medical Center and Boston University School of Medicine. 3. Makerere University-Boston Medical Center Research Collaboration. 4. Department of Biostatistics, Boston University School of Public Health, Massachusetts. 5. Department of Microbiology, Makerere University College of Health Sciences. 6. Makerere University-Boston Medical Center Research Collaboration Mulago Hospital Tuberculosis Clinic, Mulago Hospital, Kampala, Uganda. 7. Pulmonary Clinical Medicine Section, Cardiovascular and Pulmonary Branch, Division of Intramural Research, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland.
Abstract
BACKGROUND: Tuberculosis disease develops in only 5%-10% of humans infected with Mycobacterium tuberculosis The mechanisms underlying this variability remain poorly understood. We recently demonstrated that colony-forming units of M. tuberculosis in cough-generated aerosols are a better predictor of infection than the standard sputum acid-fast bacilli smear. We hypothesized that cough aerosol cultures may also predict progression to tuberculosis disease in contacts. METHODS: We conducted a retrospective cohort study of 85 patients with smear-positive tuberculosis and their 369 household contacts in Kampala, Uganda. Index case patients underwent a standard evaluation, and we cultured M. tuberculosis from cough aerosols. Contacts underwent a standard evaluation at enrollment, and they were later traced to determine their tuberculosis status. RESULTS: During a median follow-up of 3.9 years, 8 (2%) of the contacts developed tuberculosis disease. In unadjusted and adjusted analyses, incident tuberculosis disease in contacts was associated with sputum Mycobacterial Growth Indicator Tube culture (odds ratio, 8.2; 95% confidence interval, 1.1-59.2; P = .04), exposure to a high-aerosol tuberculosis case patient (6.0, 1.4-25.2; P = .01), and marginally, human immunodeficiency virus in the contact (6.11; 0.89-41.7; P = .07). We present data demonstrating that sputum and aerosol specimens measure 2 related but different phenomena. CONCLUSIONS: We found an increased risk of tuberculosis progression among contacts of high-aerosol case patients. The hypothesis that a larger infectious inoculum, represented by high aerosol production, determines the risk of disease progression deserves evaluation in future prospective studies.
BACKGROUND:Tuberculosis disease develops in only 5%-10% of humans infected with Mycobacterium tuberculosis The mechanisms underlying this variability remain poorly understood. We recently demonstrated that colony-forming units of M. tuberculosis in cough-generated aerosols are a better predictor of infection than the standard sputum acid-fast bacilli smear. We hypothesized that cough aerosol cultures may also predict progression to tuberculosis disease in contacts. METHODS: We conducted a retrospective cohort study of 85 patients with smear-positive tuberculosis and their 369 household contacts in Kampala, Uganda. Index case patients underwent a standard evaluation, and we cultured M. tuberculosis from cough aerosols. Contacts underwent a standard evaluation at enrollment, and they were later traced to determine their tuberculosis status. RESULTS: During a median follow-up of 3.9 years, 8 (2%) of the contacts developed tuberculosis disease. In unadjusted and adjusted analyses, incident tuberculosis disease in contacts was associated with sputum Mycobacterial Growth Indicator Tube culture (odds ratio, 8.2; 95% confidence interval, 1.1-59.2; P = .04), exposure to a high-aerosol tuberculosis case patient (6.0, 1.4-25.2; P = .01), and marginally, human immunodeficiency virus in the contact (6.11; 0.89-41.7; P = .07). We present data demonstrating that sputum and aerosol specimens measure 2 related but different phenomena. CONCLUSIONS: We found an increased risk of tuberculosis progression among contacts of high-aerosol case patients. The hypothesis that a larger infectious inoculum, represented by high aerosol production, determines the risk of disease progression deserves evaluation in future prospective studies.
Authors: Rosa Sloot; Maarten F Schim van der Loeff; Peter M Kouw; Martien W Borgdorff Journal: Am J Respir Crit Care Med Date: 2014-11-01 Impact factor: 21.405
Authors: Rolf J F Ypma; Hester Korthals Altes; Dick van Soolingen; Jacco Wallinga; W Marijn van Ballegooijen Journal: Epidemiology Date: 2013-05 Impact factor: 4.822
Authors: Kevin P Fennelly; John W Martyny; Kayte E Fulton; Ian M Orme; Donald M Cave; Leonid B Heifets Journal: Am J Respir Crit Care Med Date: 2003-12-04 Impact factor: 21.405
Authors: B López; D Aguilar; H Orozco; M Burger; C Espitia; V Ritacco; L Barrera; K Kremer; R Hernandez-Pando; K Huygen; D van Soolingen Journal: Clin Exp Immunol Date: 2003-07 Impact factor: 4.330
Authors: Hassan Mahomed; Tony Hawkridge; Suzanne Verver; Deborah Abrahams; Lawrence Geiter; Mark Hatherill; Rodney Ehrlich; Willem A Hanekom; Gregory D Hussey Journal: PLoS One Date: 2011-03-29 Impact factor: 3.240
Authors: Grant Theron; Jason Limberis; Rouxjeane Venter; Liezel Smith; Elize Pietersen; Aliasgar Esmail; Greg Calligaro; Julian Te Riele; Marianna de Kock; Paul van Helden; Tawanda Gumbo; Taane G Clark; Kevin Fennelly; Robin Warren; Keertan Dheda Journal: Nat Med Date: 2020-06-29 Impact factor: 53.440
Authors: Leonardo Martinez; María Eugenia Castellanos; Benjamin D Hallowell; Christopher C Whalen Journal: Am J Respir Crit Care Med Date: 2017-02-15 Impact factor: 21.405
Authors: Palwasha Y Khan; Tom A Yates; Muhammad Osman; Robin M Warren; Yuri van der Heijden; Nesri Padayatchi; Edward A Nardell; David Moore; Barun Mathema; Neel Gandhi; Vegard Eldholm; Keertan Dheda; Anneke C Hesseling; Valerie Mizrahi; Roxana Rustomjee; Alexander Pym Journal: Lancet Infect Dis Date: 2018-12-13 Impact factor: 25.071
Authors: Benjamin Patterson; Carl Morrow; Vinayak Singh; Atica Moosa; Melitta Gqada; Jeremy Woodward; Valerie Mizrahi; Wayne Bryden; Charles Call; Shwetak Patel; Digby Warner; Robin Wood Journal: Gates Open Res Date: 2018-06-08
Authors: Courtney R Plumlee; Fergal J Duffy; Benjamin H Gern; Jared L Delahaye; Sara B Cohen; Caleb R Stoltzfus; Tige R Rustad; Scott G Hansen; Michael K Axthelm; Louis J Picker; John D Aitchison; David R Sherman; Vitaly V Ganusov; Michael Y Gerner; Daniel E Zak; Kevin B Urdahl Journal: Cell Host Microbe Date: 2020-11-02 Impact factor: 21.023
Authors: Jason D Simmons; Catherine M Stein; Chetan Seshadri; Monica Campo; Galit Alter; Sarah Fortune; Erwin Schurr; Robert S Wallis; Gavin Churchyard; Harriet Mayanja-Kizza; W Henry Boom; Thomas R Hawn Journal: Nat Rev Immunol Date: 2018-09 Impact factor: 108.555